Trial Profile
Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 May 2023
Price :
$35
*
At a glance
- Drugs Mifepristone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Aug 2021 Status changed from recruiting to discontinued.
- 01 May 2020 Planned End Date changed from 1 May 2020 to 1 May 2021.
- 01 May 2020 Planned primary completion date changed from 1 May 2020 to 1 May 2021.